2024, 4+, Analisi statistiche e metanalisi, Anno, Autore, Damuzzo, Del Bono, Gasperoni, Impact factor, Messori, Ossato, Pubblicazioni, Topic
Efficacy of Immune Checkpoint Inhibitors vs. Tyrosine Kinase Inhibitors/Everolimus in Adjuvant Renal Cell Carcinoma: Indirect Comparison of Disease-Free Survival
2-3, 2023, Analisi statistiche e metanalisi, Autore, Chiumente, Mengato, Messori, Pubblicazioni, Rivano
Tislelizumab plus chemotherapy vs. pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials
2023, 4+, Analisi statistiche e metanalisi, Anno, Autore, Cancanelli, Chiumente, Damuzzo, Di Spazio, Impact factor, Mengato, Messori, Ossato, Pubblicazioni, Rivano, Topic
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses
2022, 4+, Analisi statistiche e metanalisi, Autore, Cancanelli, Chiumente, Di Spazio, Impact factor, Mengato, Messori, Pubblicazioni, Rivano, Topic
Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials.
1-2, 2022, Analisi statistiche e metanalisi, Autore, Cancanelli, Chiumente, Damuzzo, Impact factor, Mengato, Messori, Ossato, Pubblicazioni, Rivano, Topic